Surgery Better Than Obesity Drugs for Some With MASLD

This post was originally published on Medscape

You will shortly be re-directed to the publisher's website

Although popular obesity medications appear promising, bariatric surgery may be better for certain patients with metabolic dysfunction–associated steatotic liver disease, new study results showed.
Medscape Medical News